Skip to main content

Overview

Padmaja Kandula, MD is the Director of Clinical Neurophysiology Fellowship at the Weill Cornell Epilepsy Center. She received her medical degree at Northeastern Ohio University College of Medicine in Ohio, followed by a residency in neurology at Vanderbilt University Medical Center and two fellowships in Clinical Neurophysiology/Epilepsy and Intraoperative Surgical Monitoring, both at Weill Cornell Medical College. She is certified by The American Board of Psychiatry and Neurology and the American Board of Clinical Neurophysiology. Her major area of interest is epilepsy. Within epilepsy, subspecialty areas of interest include epilepsy surgery and presurgical workup, intensive care neurologic monitoring (ICU monitoring), neuro-oncology and epilepsy, and women's issues and epilepsy.

Highlights

  1. 1
    Seizure · 2021
    PMID: 34896815DOISenior author13 citations

Publications

24 publications

Clinical research

3 studies

Active

1 study
  • PI
    New Onset Refractory Status Epilepticus
    Daniel Raymond Wong Neurological Research Fund · OPEN TO ACCRUAL (as of 2020)
Completed & closed trials (2)
  • PI
    A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy
    PHASE3 · Xenon Pharmaceuticals Inc. · IRB STUDY CLOSURE (as of 2025)
    Focal Epilepsy; Tonic-Clonic Seizures
    NCT05718817
  • PI
    A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
    PHASE3 · Xenon Pharmaceuticals Inc. · IRB STUDY CLOSURE (as of 2025)
    Focal Onset Seizures
    NCT05614063